In April, the heat of private equity research institutions has increased, with a focus on the electronic and pharmaceutical biotechnology sectors.

With the warming of market sentiment, the research enthusiasm of private equity institutions has significantly increased. The latest statistics from Shenzhen Qianhai Pai Pai Wang Fund Sales Co., Ltd. show that in April, a total of 1189 private equity institutions conducted research on 639 A-share listed companies, with a total of 7647 research visits, a month-on-month increase of 117.68%. Industry insiders believe that the surge in the frequency of research by private equity institutions not only reflects the institutional investors' recognition of the current market valuation levels, but also suggests that the market may attract more incremental funds in the future.